Article Details

How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna

Retrieved on: 2021-06-30 14:17:40

Tags for this article:

Click the tags to see associated articles and topics

How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna . View article details on hiswai:

Excerpt

Jennifer Doudna, 2020 Nobel Prize winner in chemistry for CRISPR gene editing and co-founder of Intellia Therapeutics, on future of the breakthrough technology.

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo